Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes

Journal of Neuroimmunology

Volumn 74, Issue 1-2, 1997, Pages 198-204

  Rubeša, Gordana ^a   Podack, Eckhard R ^b   Sepčić, Juraj ^a   Rukavina, Daniel ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CTL; multiple sclerosis; NK; perforin; peripheral blood lymphocytes

Indexed keywords

CD16 ANTIGEN; CD4 ANTIGEN; PERFORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030890793     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00236-6     Document Type: Article

References (35)

1. Cserr, H.F. and Knopf, P.M. (1992) Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view. Immunol. Today 13, 507-512.
2. Fabry, Z., Raine, C.S. and Hart, M.N. (1994) Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol. Today 15, 218-224.
3. Gallo, P., Piccinno, M.G., Pagni, S., Argentiero, V., Biometto, B., Bozza, F. and Tavolato, B. (1989) Immune activation in multiple sclerosis: Study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebrospinal fluid. J. Neurol. Sci. 92, 9-15.
4. + (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis. J. Neuroimmunol. 33, 97-102.
5. Griffiths, G.M. and Mueller, C. (1991) Expression of perform and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells. Immunol. Today 12, 415-419.
6. Griffiths, G.M., Alpert, S., Lambert, E., McGuire, J. and Weissman, I.L. (1992) Perform and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc. Natl. Acad. Sci. 89, 549-553.
7. Hafler, D.A. and Weiner, H.L. (1989) MS: A CNS and systemic autoimmune disease. Immunol. Today 10, 104-107.
8. Hameed, A., Olsen, K.J., Cheng, L., Fox, W.M. III, Hruban, R.H. and Podack, E.R. (1992) Immunohistochemical identification of cytotoxic lymphocytes using human perform monoclonal antibody. Am. J. Pathol. 140, 1025-1029.
9. Hammond, D.M., Nagarkatti, P.S., Goté, L.R., Seth, A., Hassuneh, M.R. and Nagarkatti, M. (1993) Double negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perform gene. J. Exp. Med. 178, 2225-2230.
10. Held, W., Meyermann, R., Qin, Y. and Mueller, C. (1993) Perform and tumor necrosis factor α in the pathogenesis of experimental allergic encephalomyelitis: Comparison of autoantigen induced and transferred disease in Lewis rats. J. Autoimmun. 6, 311-322.
11. Kurtzke, J.F. (1961) On the evaluation of disability in multiple sclerosis. Neurology 11, 686-694.
12. Kurtzke, J.F. (1983) Rating neurological impairment in multiple sclerosis: An expanded disability status scale. Neurology 33, 1444-1452.
13. McCarron, R.M., Racke, M., Spatz, M. and McFarlin, D.E. (1991) Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephalitogenic T lymphocytes. J. Immunol. 147, 503-508.
14. Nagler, A., Lanier, L.L., Cwirla, S. and Phillips, J.H. (1989) Comparative studies of human FcR III positive and negative natural killer cells. J. Immunol. 143, 3183-3191.
15. Nakata, M., Smyth, M.J., Norihisa, Y., Kawasaki, A., Shinkai, Y., Okumura, K. and Yagita, H. (1990) Constitutive expression of pore-forming protein in peripheral blood γ/δ T lymphocytes: Implication for their cytotoxic role in vivo. J. Exp. Med. 172, 1877-1880
16. Podack, E.R. (1991) T-cell effector functions: Mechanisms for delivery of cytotoxicity and help. Annu. Rev. Cell. Biol. 7, 479-504.
17. Podack, E.R. (1993) Lymphocyte mediated cytotoxicity. In: K.T. Preissner, S. Rosenblatt, C. Cost, J. Wegerhoff and D.F. Mosher (Eds.), Biology of Vitronectins and Their Receptors. Elsevier, Amsterdam, pp. 237-242.
18. Podack, E.R. (1995) Execution and suicide: Cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr. Opin. Immunol. 7, 11-16.
19. Podack, E.R., Deng, G., Bowen, M.A., Wu, Z., Olsen, K.J., Zakarija, M., Lichtenheld, M.G., Kägi, D., Burki, K. and Hengartner, H. (1992) T-cell mediated cytotoxicity. In: J. Gergely, M. Benczúr and A. Erdei (Eds.), Progress in Immunology, Vol. 8. Springer Hungarica, Budapest, pp. 255-259.
20. Poser, C.M., Paty, W., Scheinberg, L., McDonald, W.J., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13, 227-231.
21. Ravetch, J.V. and Kinet, J-P. (1991) Fc Receptors. Annu. Rev. Immunol. 9, 457-492.
22. Ravetch, J.V. and Perussia, B. (1989) Alternative membrane forms of Fcγ RIII (CD16) on human NK cells and neutrophils: Cell-type specific expression of two genes which differ in single nucleotide substitutions. J. Exp. Med. 170, 481-497.
23. + T-cell subset in remitting-relapsing multiple sclerosis. Ann. Neurol. 24, 192-199.
24. Rukavina, D., Rubeša, G., Gudelj, L., and Podack, E.R. (1994) Human decidual lymphocytes: Phenotype, perform expression and function. Regional Immunol. 6, 320-325.
25. Rukavina, D., Rubeša, G., Gudelj, L. Haller, H. and Podack, E.R. (1995) Characteristics of perform expressing lymphocytes within the first trimester decidua of human pregnancy. Am. J. Reprod. Immunol. 33, 394-404.
26. Satoh, J., Kim, S.U. and Kastrukoff, L.F. (1991) Lymphokine activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis. J. Neuroimmunol. 32, 111-122.
27. Scolding, N.J., Jones, J., Compston, D.A. and Morgan, B.P. (1990) Oligodendrocyte susceptibility to injury by T-cell perform. Immunology 70, 6-10.
28. Scolozzi, R., Boccafogli, A., Tola, M.R., Vicentini, L., Camerani, A., Degani, D., Granieri, E., Caniatti, L. and Paolino, E. (1992) T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 108, 93-98.
29. Selmaj, K., Plater-Zyberk, C., Rockett, K.A., Maini, R.N., Alam, R., Perkin, G.D. and Rose, F.C. (1986) Multiple sclerosis: Increased expression of interleukin-2 receptors on lymphocytes. Neurology 36, 1392-1395.
30. Sumner, H., Abraham, C., Bou-Gharios, G., Plater-Zyberg, C. and Olsen, J. (1991) Simultaneous measurement of cell surface and intracellular antigens by multiple flow cytometry. J. Immunol. Methods 136, 259-267.
31. Tuohy, V.K., Fritz, R.B. and Ben-Nun, A. (1994) Self-determinants in autoimmune demyelinating disease: Changes in T-cell response specificity. Curr. Opin. Immunol. 6, 887-891.
32. Vraneš, Z., Poljaković, Z. and Marušić, M. (1989) Natural killer cell number and activity in multiple sclerosis. J. Neurol. Sci. 94, 115-123.
33. Wu, Z., Podack, E.R., McKenzie, J.M., Olsen, K.J. and Zakarija, M. (1994) Perform expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin. Exp. Immunol. 98, 470-477.
34. Yagita, H., Nakata, M., Kawasaki, A., Shinkai, Z. and Okumura, K. (1992) The role of perform in lymphocyte mediated cytolysis. Adv. Immunol. 51, 215-242.
35. Young, L.H., Joag, S.V., Lin, P.Y., Luo, S.F., Zheng, L.M., Liu, C.C. and Young, J.D. (1992) Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis. Am. J. Pathol. 140, 1261-1268.